Mental Health Bulletin, July 2008

Breast Cancer May 2016

This bulletin covers aspects of breast cancer, and should be of interest to multidisciplinary teams working in this area.

Sections can include:  Combined Modality Therapies  Drug Therapy  Pathology, Staging, Polymorphisms & Biomarkers  Prognosis, Survival & Risk Factors  Radiotherapy & Imaging  Supportive Care & Symptom Management  Surgery

Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at www.knowledge.scot.nhs.uk/

If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at www.quest.scot.nhs.uk

This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites.

Compiled by: Kirsty Coltart Subject Librarian Beatson West of Scotland Cancer Centre 0141 301 7285, [email protected]

1 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network GENERAL

Gradishar, W.J., Anderson, B.O., Balassanian, R., et al. (2016). Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 14,3:324-354.

Paluch-Shimon, S., Pagani, O., Partridge, A.H., et al. (2016). Second international consensus guidelines for breast cancer in young women (BCY2). Breast 26,87-99.

Thomssen, C., Augustin, D., Ettl, J., et al. (2016). ABC3 Consensus: Assessment by a German Group of Experts. Breast Care 11,1:61-70.

COMBINED MODALITY THERAPIES

Datta, N.R., Puric, E., Klingbiel, D., et al. (2016). Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis. International journal of radiation oncology, biology, physics 94,5:1073-1087.

Forbes, J.F., Sestak, I., Howell, A., et al. (2016). Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. Lancet 387,10021:866-873.

Ganz, P.A., Cecchini, R.S., Julian, T.B., et al. (2016). Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet 387,10021:857-865.

Margolese, R.G., Cecchini, R.S., Julian, T.B., et al. (2016). Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. Lancet 387,10021:849-856.

DRUG & TARGETED THERAPY

Aftimos, P., Polastro, L., Ameye, L., et al. (2016). Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial. European journal of cancer 60,117-124.

Bellet, M., Gray, K.P., Francis, P.A., et al. (2016). Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy. Journal of Clinical Oncology 34,14:1584- 1593.

Bonnefoi, H., Grellety, T., Tredan, O., et al. (2016). A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1). Annals of Oncology 27,5:812-818.

Burstein, H.J., Lacchetti, C., Anderson, H., et al. (2016). Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. Journal of Clinical Oncology 34,14:1689-1701.

2 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Chan, A., Delaloge, S., Holmes, F.A., et al. (2016). Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncology 17,3:367-377.

Chavez-MacGregor, M., Clarke, C.A., Lichtensztajn, D.Y., et al. (2016). Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer. JAMA Oncology 2,3:322-329.

Coombes, R.C., Kilburn, L.S., Tubiana-Mathieu, N., et al. (2016). Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer. European journal of cancer 60,146-153.

Freedman, R.A., Gelman, R.S., Wefel, J.S., et al. (2016). Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases. Journal of Clinical Oncology 34,9:945-952.

Graham, J., Pitz, M., Gordon, V., et al. (2016). Clinical predictors of benefit from fulvestrant in advanced breast cancer: A Meta-analysis of randomized controlled trials. Cancer treatment reviews 45,1-6.

Janni, W., Harbeck, N., Rack, B., et al. (2016). Randomised phase III trial of FEC120 vs EC- docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study. British journal of cancer 114,8:863-871.

Kadakia, K.C., Snyder, C.F., Kidwell, K.M., et al. (2016). Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer. Oncologist 21,5:539-546.

Mobus, V. (2016). Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients. Breast Care 11,1:8-12.

Rampurwala, M., Wisinski, K.B. and O'Regan, R. (2016). Role of the androgen receptor in triple-negative breast cancer. Clinical Advances in Hematology & Oncology 14,3:186-193.

Reyes, S.A., King, T.A., Fei, K., et al. (2016). Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer. Annals of Surgical Oncology 23,5:1537-1542.

Ribi, K., Luo, W., Bernhard, J., et al. (2016). Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial. Journal of Clinical Oncology 34,14:1601-1610.

Ryden, L., Heibert Arnlind, M., Vitols, S., et al. (2016). Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials. Breast 26,106-114.

Shiba, E., Yamashita, H., Kurebayashi, J., et al. (2016). A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer. Breast Cancer 23,3:499-509.

Smith, S.G., Sestak, I., Forster, A., et al. (2016). Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis. Annals of Oncology 27,4:575-590.

Truong, J., Lee, E.K., Trudeau, M.E., et al. (2016). Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysis. Annals of Oncology 27,4:608-618.

3 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Twelves, C., Jove, M., Gombos, A., et al. (2016). Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer. Critical Reviews in Oncology- Hematology 100,74-87.

Untch, M., Jackisch, C., Schneeweiss, A., et al. (2016). Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial. Lancet Oncology 17,3:345-356.

Zdenkowski, N., Forbes, J.F., Boyle, F.M., et al. (2016). Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial. Annals of Oncology 27,5:806-812.

PATHOLOGY, STAGING, POLYMORPHISMS, BIOMARKERS

Bartlett, J.M.S., Bayani, J., Marshall, A., et al. (2016). Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others. Journal of the National Cancer Institute 108,9:

Harris, L.N., Ismaila, N., McShane, L.M., et al. (2016). Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 34,10:1134-1150.

Yang, S.X., Polley, E. and Lipkowitz, S. (2016). New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer. Cancer treatment reviews 45,87-96.

PROGNOSIS, SURVIVAL, RISK FACTORS

Colleoni, M., Sun, Z., Price, K.N., et al. (2016). Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V. Journal of Clinical Oncology 34,9:927-935.

Lee, E.S., Jung, S.Y., Kim, J.Y., et al. (2016). Identifying the potential long-term survivors among breast cancer patients with distant metastasis. Annals of Oncology 27,5:828-833.

Schoenberger, Y., Benz, R., McNees, P., et al. (2016). Patient-centered outcome evaluation of the Rural Breast Cancer Survivors Intervention. Supportive Care in Cancer 24,4:1841- 1848.

RADIOTHERAPY AND IMAGING

Bloomquist, E.V., Ajkay, N., Patil, S., et al. (2016). A Randomized Prospective Comparison of Patient-Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization. Breast Journal 22,2:151-157.

Coombs, N.J., Coombs, J.M., Vaidya, U.J., et al. (2016). Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT. BMJ Open 6,5:e010703.

Cooper, B.T., Formenti-Ujlaki, G.F., Li, X., et al. (2016). Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus

4 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Weekly Boost to the Tumor Bed. International journal of radiation oncology, biology, physics 95,2:571-578.

Finkel, M.A., Cooper, B.T., Li, X., et al. (2016). Quality of Life in Women Undergoing Breast Irradiation in a Randomized, Controlled Clinical Trial Evaluating Different Tumor Bed Boost Fractionations. International journal of radiation oncology, biology, physics 95,2:579- 589.

Garcia, E.M., Crowley, J., Hagan, C., et al. (2016). Evolution of Imaging in Breast Cancer. Clinical Obstetrics & Gynecology 59,2:322-335.

Haviland, J.S., Hopwood, P., Mills, J., et al. (2016). Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer. Clinical Oncology (Royal College of Radiologists) 28,6:345-353.

Hylton, N.M., Gatsonis, C.A., Rosen, M.A., et al. (2016). Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology 279,1:44- 55.

Iacconi, C., Galman, L., Zheng, J., et al. (2016). Multicentric Cancer Detected at Breast MR Imaging and Not at Mammography: Important or Not?. Radiology 279,2:378-384.

Juneja, P., Bonora, M., Haviland, J.S., et al. (2016). Does breast composition influence late adverse effects in breast radiotherapy?. Breast 26,25-30.

Konig, J., van Ewijk, R., Kuhr, K., et al. (2016). Radiotherapy effects on early breast cancer survival in observational and randomized studies: a systematic analysis of advantages, disadvantages and differences between the two study types. Breast Cancer 23,3:415-424.

Lange, M., Reimer, T., Hartmann, S., et al. (2016). The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ. Breast 26,73-79.

Maxwell, A.J., Bundred, N.J., Harvey, J., et al. (2016). A randomised pilot study comparing 13 G vacuum-assisted biopsy and conventional 14 G core needle biopsy of axillary lymph nodes in women with breast cancer. Clinical radiology 71,6:551-557.

Rominger, M., Berg, D., Frauenfelder, T., et al. (2016). Which factors influence MRI- pathology concordance of tumour size measurements in breast cancer?. European radiology 26,5:1457-1465.

Verma, V., Vicini, F., Tendulkar, R.D., et al. (2016). Role of Internal Mammary Node Radiation as a Part of Modern Breast Cancer Radiation Therapy: A Systematic Review. International journal of radiation oncology, biology, physics 95,2:617-631.

Yamauchi, C., Sekiguchi, K., Nishioka, A., et al. (2016). The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition. Breast Cancer 23,3:378-390.

Zhu, Y., Zhou, W., Zhou, J., et al. (2016). Axillary Staging of Early-Stage Invasive Breast Cancer by Ultrasound-Guided Fine-Needle Aspiration Cytology: Which Ultrasound Criteria for Classifying Abnormal Lymph Nodes Should Be Adopted in the Post-ACOSOG Z0011 Trial Era?. Journal of Ultrasound in Medicine 35,5:885-893.

5 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network SUPPORTIVE CARE AND SYMPTOM MANAGEMENT

Ahmed, K., Marchand, E., Williams, V., et al. (2016). Development and pilot testing of a psychosocial intervention program for young breast cancer survivors. Patient Education & Counseling 99,3:414-420.

Beesley, H., Goodfellow, S., Holcombe, C., et al. (2016). The intensity of breast cancer patients' relationships with their surgeons after the first meeting: Evidence that relationships are not 'built' but arise from attachment processes. European Journal of Surgical Oncology 42,5:679-684.

Boyle, T., Vallance, J.K., Ransom, E.K., et al. (2016). How sedentary and physically active are breast cancer survivors, and which population subgroups have higher or lower levels of these behaviors?. Supportive Care in Cancer 24,5:2181-2190.

Cheung, Y.T., Ong, Y.Y., Ng, T., et al. (2016). Assessment of mental health literacy in patients with breast cancer. Journal of Oncology Pharmacy Practice 22,3:437-447.

Chiu, H., Shyu, Y., Chang, P., et al. (2016). Effects of Acupuncture on Menopause-Related Symptoms in Breast Cancer Survivors: A Meta-analysis of Randomized Controlled Trials. Cancer nursing 39,3:228-237.

Cho, Y., Do, J., Jung, S., et al. (2016). Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection. Supportive Care in Cancer 24,5:2047-2057.

Cornette, T., Vincent, F., Mandigout, S., et al. (2016). Effects of home-based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant chemotherapy (SAPA): a randomized controlled trial. European journal of physical & rehabilitation medicine 52,2:223-232.

Eda, K., Uzer, K., Murat, T., et al. (2016). The effects of enteral glutamine on radiotherapy induced dermatitis in breast cancer. Clinical Nutrition 35,2:436-439.

Farthmann, J., Hanjalic-Beck, A., Veit, J., et al. (2016). The impact of chemotherapy for breast cancer on sexual function and health-related quality of life. Supportive Care in Cancer 24,6:2603-2609.

Giron, P.S., Haddad, C.A.S., Lopes de Almeida Rizzi,Samantha Karlla, et al. (2016). Effectiveness of acupuncture in rehabilitation of physical and functional disorders of women undergoing breast cancer surgery. Supportive Care in Cancer 24,6:2491-2496.

Goldberg, D.R., Wardell, D.W., Kilgarriff, N., et al. (2016). An Initial Study Using Healing Touch for Women Undergoing a Breast Biopsy. Journal of Holistic Nursing 34,2:123-134.

Goldfarb, S.B., Kamer, S.A., Oppong, B.A., et al. (2016). Fertility Preservation for the Young Breast Cancer Patient. Annals of Surgical Oncology 23,5:1530-1536.

Halbach, S.M., Enders, A., Kowalski, C., et al. (2016). Health literacy and fear of cancer progression in elderly women newly diagnosed with breast cancer-A longitudinal analysis. Patient Education & Counseling 99,5:855-862.

Jatoi, A., Muss, H., Allred, J.B., et al. (2016). Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301). Psycho-oncology 25,4:441-446.

6 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Johns, C., Seav, S.M., Dominick, S.A., et al. (2016). Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Research & Treatment 156,3:415-426.

Lee, K.H., Kim, J., Lee, M.H., et al. (2016). A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09. Supportive Care in Cancer 24,4:1709-1717.

Lesi, G., Razzini, G., Musti, M.A., et al. (2016). Acupuncture As an Integrative Approach for the Treatment of Hot Flashes in Women With Breast Cancer: A Prospective Multicenter Randomized Controlled Trial (AcCliMaT). Journal of Clinical Oncology 34,15:1795-1802.

Leyland-Jones, B., Bondarenko, I., Nemsadze, G., et al. (2016). A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy. Journal of Clinical Oncology 34,11:1197-1207.

Ligibel, J.A., Giobbie-Hurder, A., Shockro, L., et al. (2016). Randomized trial of a physical activity intervention in women with metastatic breast cancer. Cancer 122,8:1169-1177.

Llombart-Cussac, A., Ramos, M., Dalmau, E., et al. (2016). Incidence of chemotherapy- induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study. European journal of cancer 58,122-129.

Lombard, J.M., Zdenkowski, N., Wells, K., et al. (2016). Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options. Supportive Care in Cancer 24,5:2139-2146.

Montemurro, F., Mittica, G., Cagnazzo, C., et al. (2016). Self-evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer. JAMA Oncology 2,4:445-452.

Nicholas Zdenkowski, Butow, P., Tesson, S., et al. (2016). A systematic review of decision aids for patients making a decision about treatment for early breast cancer. Breast 26,31- 45.

Phillips, K., Regan, M.M., Ribi, K., et al. (2016). Adjuvant ovarian function suppression and cognitive function in women with breast cancer. British journal of cancer 114,9:956-964.

Raftopoulos, H., Laadem, A., Hesketh, P.J., et al. (2016). Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies. Supportive Care in Cancer 24,4:1517-1525.

Richards, I., Tesson, S., Porter, D., et al. (2016). Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour. European Journal of Oncology Nursing 21,57-65.

Schwentner, L., Van Ewijk, R., Kuhn, T., et al. (2016). Exploring patient- and physician- related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II. Supportive Care in Cancer 24,6:2759-2766.

Serpico, V., Liepert, A.E., Boucher, K., et al. (2016). The Effect of Previsit Education in Breast Cancer Patients: A Study of a Shared-decision-making Tool. American Surgeon 82,3:259-265.

7 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Wisniewska, I., Jochymek, B., Lenart-Lipinska, M., et al. (2016). The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. Breast Cancer 23,2:178-182.

Williams, F. and Jeanetta, S.C. (2016). Lived experiences of breast cancer survivors after diagnosis, treatment and beyond: qualitative study. Health Expectations 19,3:631-642.

SURGERY

Bodilsen, A., Bjerre, K., Offersen, B.V., et al. (2016). Importance of margin width in breast- conserving treatment of early breast cancer. Journal of surgical oncology 113,6:609-615.

Gebruers, N. and Tjalma, W.A.A. (2016). Clinical feasibility of Axillary Reverse Mapping and its influence on breast cancer related lymphedema: a systematic review. European Journal of Obstetrics, Gynecology, & Reproductive Biology 200,117-122.

Gentilini, O., Botteri, E., Dadda, P., et al. (2016). Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial. European Journal of Surgical Oncology 42,5:685-689.

Hwang, E.S., Locklear, T.D., Rushing, C.N., et al. (2016). Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy. Journal of Clinical Oncology 34,13:1518- 1527.

Jinno, H., Inokuchi, M., Ito, T., et al. (2016). The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition. Breast Cancer 23,3:367-377.

Kell, M.R. and Sharma, S. (2016). Minimally invasive, maximal outcomes in breast surgery. Surgeon Journal of the Royal Colleges of Surgeons of Edinburgh & Ireland 14,3:174-178.

Klonoff-Cohen, H., An, R., Fries, T., et al. (2016). Timing of breast cancer surgery, menstrual phase, and prognosis: Systematic review and meta-analysis. Critical Reviews in Oncology- Hematology 102,1-14.

Oh, D.D., Flitcroft, K., Brennan, M.E., et al. (2016). Patterns and outcomes of breast reconstruction in older women - A systematic review of the literature. European Journal of Surgical Oncology 42,5:604-615.

Ojala, K., Vironen, J.H., Mattila, K., et al. (2016). Feasibility of Day Surgery in Patients With Breast Conservation and Sentinel Node Biopsy: A Randomized Controlled Trial. Scandinavian Journal of Surgery: SJS 105,1:29-34.

Razdan, S.N., Patel, V., Jewell, S., et al. (2016). Quality of life among patients after bilateral prophylactic mastectomy: a systematic review of patient-reported outcomes. Quality of Life Research 25,6:1409-1421.

Richards, P., Ward, S., Morgan, J., et al. (2016). The use of surgery in the treatment of ER+ early stage breast cancer in England: Variation by time, age and patient characteristics. European Journal of Surgical Oncology 42,4:489-496.

Rubio, I.T., Ahmed, M., Kovacs, T., et al. (2016). Margins in breast conserving surgery: A practice-changing process. European Journal of Surgical Oncology 42,5:631-640.

Teshome, M., Wei, C., Hunt, K.K., et al. (2016). Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis. Annals of Surgical Oncology 23,5:1508-1514.

8 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network Winters, Z.E., Afzal, M., Balta, V., et al. (2016). Patient-reported outcomes and their predictors at 2- and 3-year follow-up after immediate latissimus dorsi breast reconstruction and adjuvant treatment. British Journal of Surgery 103,5:524-536.

Yiannakopoulou, E.C. and Mathelin, C. (2016). Oncoplastic breast conserving surgery and oncological outcome: Systematic review. European Journal of Surgical Oncology 42,5:625- 630.

Please note that the journal articles you are accessing are subject to the terms and conditions imposed by the publisher, so there will be a limit on the number of articles an individual may download or print from a single issue of a journal. You can consult your local NHSGGC library with any queries.

If you have any questions regarding this or any other library services please contact Library staff – contact details are at the beginning of the bulletin.

Sources used for this bulletin: OVID MEDLINE, SIGN, NICE, Healthcare Improvement Scotland

9 Breast Cancer, May 2016 Kirsty Coltart, Subject Librarian, NHSGGC Library Network